MarketCap
Facebook
X
TelegramAnnual report 2024
added 02-28-2026
ICON Public Limited Company ROE Ratio 2011-2026 | ICLR
Annual ROE Ratio ICON Public Limited Company
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.31 | 6.63 | 5.95 | 1.9 | 17.96 | 23.11 | 23.82 | 23.63 | 27.74 | 31.39 | 18.15 | 11.29 | 7.34 | 3.36 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 31.39 | 1.9 | 15.04 |
Quarterly ROE Ratio ICON Public Limited Company
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.78 | 1.59 | -0.98 | 2.66 | 7.48 | 12.84 | 19.37 | 18.76 | 14.44 | 20.75 | 21.71 | 24.82 | 18.66 | 25.0 | 25.02 | 24.68 | 18.62 | 25.19 | 25.44 | 25.93 | 20.43 | 26.87 | 26.74 | 27.15 | 20.61 | 27.74 | 28.43 | 27.45 | 18.45 | 23.43 | 21.27 | 19.63 | 12.83 | 16.08 | 14.36 | 13.08 | 8.54 | 11.01 | 10.22 | 8.58 | 4.91 | 4.53 | 1.68 | 2.35 | 2.66 | -0.38 | 1.84 | 1.2 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 28.43 | -0.98 | 15.34 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
22.45 | $ 121.02 | 1.7 % | $ 36.8 B |  USA |
 |
Anixa Biosciences
ANIX
|
-72.07 | $ 2.96 | 4.71 % | $ 96.1 K | USA |
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 22.3 | -5.27 % | $ 234 M |  China |
 |
Celcuity
CELC
|
-96.68 | $ 111.31 | 3.64 % | $ 4.39 B | USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Castle Biosciences
CSTL
|
4.0 | $ 28.14 | 2.07 % | $ 782 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 180.97 | 2.92 % | $ 8.97 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 14.14 | 2.56 % | $ 428 M | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K |  Israel |
|
Biodesix
BDSX
|
-205.65 | $ 14.71 | -5.1 % | $ 1.91 B | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
IDEXX Laboratories
IDXX
|
65.99 | $ 650.0 | 2.28 % | $ 52.3 B | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 129.59 | 0.02 % | $ 20.6 B | USA |
 |
BioNano Genomics
BNGO
|
-316.66 | $ 1.14 | 1.88 % | $ 1.45 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 208.63 | 0.13 % | $ 23.2 B | USA |
 |
Danaher Corporation
DHR
|
6.88 | $ 205.32 | 0.63 % | $ 146 B | USA |
 |
Organovo Holdings
ONVO
|
-23.71 | - | -2.3 % | $ 19.4 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | $ 103.51 | 0.13 % | $ 19.5 B | USA |
 |
Bioventus
BVS
|
-90.0 | $ 8.42 | -3.66 % | $ 527 M | USA |
 |
DarioHealth Corp.
DRIO
|
-102.21 | $ 9.65 | -6.26 % | $ 274 M | Israel |
 |
DexCom
DXCM
|
30.46 | $ 73.39 | 0.42 % | $ 28.6 B | USA |
 |
PerkinElmer
PKI
|
3.33 | - | -0.91 % | $ 14.7 B | USA |
 |
Psychemedics Corporation
PMD
|
-62.26 | - | -1.84 % | $ 15.3 M | USA |
 |
QIAGEN N.V.
QGEN
|
2.34 | - | - | $ 10.6 B |  Niderland |
 |
Quotient Limited
QTNT
|
312.05 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Renalytix AI plc
RNLX
|
425.97 | - | 5.66 % | $ 22.7 M | Britain |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 19.28 | 2.56 % | $ 1.03 B | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 281.11 | -0.69 % | $ 23.4 B | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 77.74 | -1.4 % | $ 5.25 B | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | Israel |
 |
Guardant Health
GH
|
419.18 | $ 93.95 | 0.7 % | $ 11.8 B | USA |
 |
IQVIA Holdings
IQV
|
20.91 | $ 177.49 | 2.0 % | $ 30.5 B | USA |
 |
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 290.77 | -1.92 % | $ 26.6 B | Schweiz |
 |
Brainsway Ltd.
BWAY
|
-27.43 | $ 12.53 | 8.11 % | $ 99.4 M | Israel |
 |
Co-Diagnostics
CODX
|
-41.08 | - | - | $ 79.8 M | USA |
 |
Myriad Genetics
MYGN
|
-99.43 | $ 5.35 | 1.04 % | $ 495 M | USA |